Related Experiment Video
Updated: Jun 1, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Effective use of polymyxin B hemoperfusion in septic shock complicated by urosepsis
P Malleshappa1, R Ranganath, A P Chaudhari
1Department of Nephrology, Lilavati Hospital and Research Centre, Mumbai, India.
Abstract:
Direct hemoperfusion using polymyxin B-immobilized fiber (PMX-DHP) is an established treatment method for septic shock caused by Gram-negative infections. Here we report one instance in which PMX-DHP therapy has been used successfully in a patient with septic shock from urosepsis. After antibiotic therapy, direct hemoperfusion using polymyxin B helped in cardiovascular stability. The patient recovered from the shock within a few days after treatment with polymyxin-B hemoperfusion. As far as we are aware, this is the first reported case of effective treatment of urosepsis complicated by septic shock using PMX-DHP therapy in India.
Insights
Polymyxin B-immobilized fiber direct hemoperfusion (PMX-DHP) successfully treated septic shock from urosepsis. This innovative therapy improved cardiovascular stability and led to patient recovery in India.
Area of Science:
- Nephrology
- Critical Care Medicine
- Infectious Diseases
Background:
- Septic shock from Gram-negative infections is a life-threatening condition.
- Polymyxin B-immobilized fiber direct hemoperfusion (PMX-DHP) is an established treatment for septic shock.
- Urosepsis is a common cause of Gram-negative septic shock.
Observation:
- A patient presented with septic shock secondary to urosepsis.
- The patient received antibiotic therapy followed by PMX-DHP.
- Cardiovascular stability was monitored during and after the procedure.
Findings:
- PMX-DHP therapy was successfully administered to the patient.
- The treatment resulted in improved cardiovascular stability.
- The patient recovered from septic shock within days of PMX-DHP treatment.
Implications:
- This case highlights the potential efficacy of PMX-DHP in managing urosepsis-induced septic shock.
- This represents the first reported use of PMX-DHP for urosepsis with septic shock in India.
- Further research may explore PMX-DHP as a therapeutic option for similar complex cases.
Related Concept Videos
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Acute Pyelonephritis II: Diagnostic Studies and Management
Combined Effects of Drugs: Synergism
Such synergistic combinations...
